Another so important fact is that the cutting edge technologies of IMU, CHM, RAD and now ALA can be combined to get an even better outcome for patients. It is a huge pool of experts and trial sides world wide. Apart of IMU the 3 others currently trading not far from cash value, almost zero enterprise value for so many assets with some already in clinical trials Ph 1 and Ph 2.
This Christmas Blues and the market downturn is an opportunity that doesn't come along too often.
GLTA
CHM Price at posting:
7.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)